Detalles de la búsqueda
1.
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study.
Lancet Oncol
; 22(2): 212-222, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33460574
2.
Evaluation of the Association of Polymorphisms With Palbociclib-Induced Neutropenia: Pharmacogenetic Analysis of PALOMA-2/-3.
Oncologist
; 26(7): e1143-e1155, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33955129
3.
Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer in Young Women: Emerging Data in the Era of Molecularly Targeted Agents.
Oncologist
; 25(6): e900-e908, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32176406
4.
Treatment effect of palbociclib plus endocrine therapy by prognostic and intrinsic subtype and biomarker analysis in patients with bone-only disease: a joint analysis of PALOMA-2 and PALOMA-3 clinical trials.
Breast Cancer Res Treat
; 184(1): 23-35, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32783178
5.
Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results.
Oncologist
; 22(9): 1028-1038, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28652278
6.
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial.
Lancet Oncol
; 17(4): 425-439, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26947331
7.
Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18.
Breast Cancer Res
; 18(1): 67, 2016 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-27349747
8.
Palbociclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive/HER2-Negative Advanced Metastatic Breast Cancer: Detailed Safety Analysis From a Multicenter, Randomized, Placebo-Controlled, Phase III Study (PALOMA-3).
Oncologist
; 21(10): 1165-1175, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27368881
9.
Crizotinib for the treatment of ALK-rearranged non-small cell lung cancer: a success story to usher in the second decade of molecular targeted therapy in oncology.
Oncologist
; 17(11): 1351-75, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22989574
10.
Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast Cancer.
J Natl Cancer Inst
; 113(3): 309-317, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32940689
11.
Predictors of prolonged benefit from palbociclib plus fulvestrant in women with endocrine-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in PALOMA-3.
Eur J Cancer
; 104: 21-31, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30308388
12.
Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer.
Nat Commun
; 9(1): 896, 2018 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29497091
13.
Palbociclib plus endocrine therapy in older women with HR+/HER2- advanced breast cancer: a pooled analysis of randomised PALOMA clinical studies.
Eur J Cancer
; 101: 123-133, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30053671
14.
PALOMA-3: Phase III Trial of Fulvestrant With or Without Palbociclib in Premenopausal and Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That Progressed on Prior Endocrine Therapy-Safety and Efficacy in Asian Patients.
J Glob Oncol
; 3(4): 289-303, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28831437
15.
NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer.
Clin Cancer Res
; 23(15): 4055-4065, 2017 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28270497
16.
Plasma ESR1 Mutations and the Treatment of Estrogen Receptor-Positive Advanced Breast Cancer.
J Clin Oncol
; 34(25): 2961-8, 2016 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27269946
Resultados
1 -
16
de 16
1
Próxima >
>>